GovGrant R&D specialists logo – A Source Advisors company

What did the Chancellor announce in the 2023 Autumn Statement?

Posted on Thursday 23 November 2023 by Akshay Thaman | IP Consultant & Policy Lead

Confirmed date for the merged R&D tax relief scheme

The headline news is that plans for a single R&D tax relief scheme, which merges the SME and RDEC schemes, is confirmed to go ahead for accounting periods starting on or after 1 April 2024. This confounds earlier speculation that there would be a delay. This does at least give us some certainty on the timelines, although it is indicative of the continued fast pace of change around R&D tax relief.
> Read more

What to look out for at next week’s Autumn Statement – November 2023

Posted on Tuesday 14 November 2023 by Akshay Thaman | IP Consultant & Policy Lead

The Autumn Statement, a pivotal moment on the UK’s fiscal calendar, promises a glimpse into the government’s economic roadmap and policy priorities. With this year’s Autumn Budget fast approaching, the government’s plans for R&D tax policy are hotly anticipated, and here is all you need to know ahead of next week’s announcement.

> Read more

HMRC releases R&D tax relief and Patent Box statistics 2023

Posted on Friday 29 September 2023 by Akshay Thaman | IP Consultant & Policy Lead

Yesterday HMRC released the latest statistics for the usage of the R&D tax relief and Patent Box schemes. Here’s an initial view of this year’s numbers.

> Read more

R&D tax relief hits the headlines for the wrong reasons

Posted on Wednesday 19 July 2023 by Akshay Thaman | IP Consultant & Policy Lead

You may have seen that the R&D tax relief schemes have been hitting the headlines again this week. There has also been a flurry of activity and information from HMRC that you may not be aware of. So, I thought I’d take this opportunity to run you through it, explain what it means for the future of the schemes and what our, GovGrant , opinion is.

> Read more

UK innovation on a global stage – what does University of Cambridge report tell us?

Posted on Monday 17 July 2023 by Akshay Thaman | IP Consultant & Policy Lead

In March 2023 the Institute for Manufacturing, University of Cambridge published the UK Innovation Report with the aim of benchmarking the UK’s industrial and innovation performance in a global context.

This comprehensive report brings together a whole range of innovation and value-added indicators and should be a key reference in any discussion about innovation policy and industrial performance in the UK.

> Read more

Intellectual Property Day – Unleashing the true value of IP for UK’s SMEs

Posted on Monday 26 April 2021 by Akshay Thaman | IP Consultant & Policy Lead

It’s World Intellectual Property Day, a day to celebrate and educate the world about the role that intellectual property (IP) rights play in encouraging innovation and how, when employed successfully, an idea can become an IP asset to create business value and drive sustainable economic growth.
> Read more

The European Patent Index 2020: Analysis of the numbers

Posted on Thursday 25 March 2021 by Akshay Thaman | IP Consultant & Policy Lead

In case you missed it, last week the European Patent Office (EPO) released its European Patent Index (EPI) for 2020 which saw the number of European patent applications filed at the EPO drop by 0.7% compared to 2019. If you would like to know more about what the European Patent Index is and why it is significant, please see my earlier blog post here. This is the last in a two part series that will dissect the data released in this year’s EPI and what it may reveal for the state of innovation for certain sectors within Europe.
> Read more

The European Patent Index 2020: An insight into European innovation trends

Posted on Wednesday 17 March 2021 by Akshay Thaman | IP Consultant & Policy Lead

This week the European Patent Office (EPO) has released its much-anticipated European Patent Index (EPI) for 2020.
> Read more

Changes in Intellectual Property practices post-Brexit

Posted on Wednesday 2 December 2020 by Akshay Thaman | IP Consultant & Policy Lead

Brexit? Is that still happening? Well yes, fortunately, or unfortunately (depending on which side of the fence you are on), and, consequently, there are changes to how certain aspects of the Intellectual Property (IP) system will operate in the UK on or after 1 January 2021. Here is your one-stop-shop for all things Brexit and IP post the end of the transition period:
> Read more

IP strategy – key to thriving in a post-covid world

Posted on Wednesday 15 July 2020 by Akshay Thaman | IP Consultant & Policy Lead

As non-essential business begins to reopen after months of non-trading, and those on furlough start to return to work, many companies across the UK are pressing the ‘resume’ button in an environment with greater volatility than ever before. This will pose challenges on an unprecedented scale; therefore, companies will be doing all they can to ensure that there is enough cash available to weather the storm that is to come.
> Read more

In our hour of need is the UK’s patent process a help or a hindrance?

Posted on Tuesday 5 May 2020 by Akshay Thaman | IP Consultant & Policy Lead

It is safe to say that the sudden emergence of Covid-19 and its impact has taken the world by surprise. It has brought economies to their knees as well as posed social challenges, but most importantly, it represents a great threat to the health and wellbeing of the most vulnerable. In these truly unprecedented times, our hopes of fighting, mitigating, and eventually, overcoming this global pandemic rest on the shoulders of innovative companies, universities and other organisations coming up with technical solutions to solve this problem, and fast.
> Read more

New grant funding announced for UK’s innovative businesses

Posted on Monday 6 April 2020 by Akshay Thaman | IP Consultant & Policy Lead

On Friday 3 April the government announced that Innovate UK, part of UK Research and Innovation, will invest up to £20 million in the funding of innovation projects that respond directly to the Covid-19 pandemic.
> Read more